This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004:15 Suppl 1:I5-I6.

doi: 10.1093/annonc/mdh650.

Familial breast cancer screening: ethical and social implications

A Paradiso¹, F Muggia

Affiliations

PMID: 15280180
DOI: 10.1093/annonc/mdh650

Comment

Familial breast cancer screening: ethical and social implications

A Paradiso et al. Ann Oncol. 2004.

. 2004:15 Suppl 1:I5-I6.

doi: 10.1093/annonc/mdh650.

Authors

A Paradiso¹, F Muggia

Affiliation

¹ Clinical Experimental Oncology Laboratory, National Cancer Institute, Bari, Italy. a.paradiso@oncologico.bari.it

PMID: 15280180
DOI: 10.1093/annonc/mdh650

No abstract available

PubMed Disclaimer

Comment on

Genetic alterations in hereditary breast cancer.
Cipollini G, Tommasi S, Paradiso A, Aretini P, Bonatti F, Brunetti I, Bruno M, Lombardi G, Schittulli F, Sensi E, Tancredi M, Bevilacqua G, Caligo MA. Cipollini G, et al. Ann Oncol. 2004;15 Suppl 1:I7-I13. doi: 10.1093/annonc/mdh651. Ann Oncol. 2004. PMID: 15280181
External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years.
Mueller CR, Kristoffersson U, Stoppa-Lyonnet D. Mueller CR, et al. Ann Oncol. 2004;15 Suppl 1:I14-I17. doi: 10.1093/annonc/mdh652. Ann Oncol. 2004. PMID: 15280182
An overview of the status of imaging screening technology for breast cancer.
Smith JA, Andreopoulou E. Smith JA, et al. Ann Oncol. 2004;15 Suppl 1:I18-I26. doi: 10.1093/annonc/mdh653. Ann Oncol. 2004. PMID: 15280183 Review.
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.
Marchetti P, Di Rocco CZ, Ricevuto E, Bisegna R, Cianci G, Calista F, Sidoni T, Porzio G, Ficorella C. Marchetti P, et al. Ann Oncol. 2004;15 Suppl 1:I27-I34. doi: 10.1093/annonc/mdh654. Ann Oncol. 2004. PMID: 15280184 Review.
Decisions and outcomes of genetic testing for inherited breast cancer risk.
Halbert CH. Halbert CH. Ann Oncol. 2004;15 Suppl 1:I35-I39. doi: 10.1093/annonc/mdh655. Ann Oncol. 2004. PMID: 15280185
Genetic testing and breast cancer: the women's point of view.
Mosconi P, Leccese A. Mosconi P, et al. Ann Oncol. 2004;15 Suppl 1:I40-I42. doi: 10.1093/annonc/mdh656. Ann Oncol. 2004. PMID: 15280186
Intensive radiologic surveillance: a focus on the psychological issues.
Warner E. Warner E. Ann Oncol. 2004;15 Suppl 1:I43-I47. doi: 10.1093/annonc/mdh657. Ann Oncol. 2004. PMID: 15280187
Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population.
Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, Distante A, Di Paola L, Paradiso A. Bruno M, et al. Ann Oncol. 2004;15 Suppl 1:I48-I54. doi: 10.1093/annonc/mdh658. Ann Oncol. 2004. PMID: 15280188
Costs and benefits of diagnosing familial breast cancer.
Møller P. Møller P. Ann Oncol. 2004;15 Suppl 1:I55-I59. doi: 10.1093/annonc/mdh659. Ann Oncol. 2004. PMID: 15280189 Review.
Genetic medicine: the balance between science and morality.
Surbone A. Surbone A. Ann Oncol. 2004;15 Suppl 1:I60-I64. doi: 10.1093/annonc/mdh660. Ann Oncol. 2004. PMID: 15280190

Similar articles

Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J, Huzarski T, Byrski T, Debniak T, Metcalfe K, Narod SA, Lubiński J. Gronwald J, et al. Breast Cancer Res Treat. 2006 Dec;100(3):239-45. doi: 10.1007/s10549-006-9261-5. Epub 2006 Jun 29. Breast Cancer Res Treat. 2006. PMID: 16807675
Cost effectiveness analysis of genetic testing for breast and ovarian cancer susceptibility genes: BRCA1 and BRCA2.
Kaldate R, Huston A, McCoy H, Cardeiro D, Noyes K. Kaldate R, et al. Breast J. 2014 May-Jun;20(3):325-6. doi: 10.1111/tbj.12269. Epub 2014 Apr 8. Breast J. 2014. PMID: 24708220 No abstract available.
BRCA screening.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2007 Nov 19;49(1274):93-4. Med Lett Drugs Ther. 2007. PMID: 18007543 No abstract available.
Breast cancer susceptibility genes.
Calzone KA. Calzone KA. Nurs Spectr (Wash D C). 1998 Nov 2;8(22):12-4; quiz 14. Nurs Spectr (Wash D C). 1998. PMID: 10542765 Review. No abstract available.
[Genetic test and prophylactic treatment in breast cancer families].
Miyoshi Y, Noguchi S. Miyoshi Y, et al. Gan To Kagaku Ryoho. 2002 Apr;29(4):512-22. Gan To Kagaku Ryoho. 2002. PMID: 11977534 Review. Japanese.

See all similar articles

Cited by

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.
Stemke-Hale K, Hennessy B, Mills GB, Mitra R. Stemke-Hale K, et al. Curr Oncol Rep. 2006 Nov;8(6):484-91. doi: 10.1007/s11912-006-0078-5. Curr Oncol Rep. 2006. PMID: 17040626 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information